Intuitive Surgical announced a 23% revenue increase to $2.77 billion in Q1 2026, driven by a 17% rise in worldwide procedures and higher placements of its da Vinci and Ion surgical systems. The company placed 431 da Vinci systems, including 232 of the latest da Vinci 5 model, and grew its installed base by 12% for da Vinci and 22% for Ion systems. Net income rose to $822 million GAAP and $901 million non-GAAP, supported by strong operational performance and share repurchases. Intuitive expects continued procedure growth and stable profit margins for 2026, despite tariff impacts.
In Q2 2026, AMD's stock surged 182.4%, driven by growth in AI workloads linked to large language models. CrowdStrike also saw strong gains of 95.6% due to a positive shift in the AI investment narrative. Conversely, Netflix's stock declined after bea...
The global blood glucose monitoring system market, valued at $16.8 billion in 2025, is projected to grow to $39.4 billion by 2035 at an 8.9% CAGR. Growth is fueled by rising diabetes prevalence, advancements in AI-enabled monitoring devices, and incr...
